Catalyst Database

Chronological list of catalyst events. Click on a ticker to view the company profile, click a drug to view prior data. Use the search box below to filter the catalyst results.

Sort Table By:

Drug | Disease (links)

Date | Stage

Volatility

NKTR

Jun 05, 2020

NKTR-358

Systemic Lupus Erythematosus.

Phase 1b (EULAR report-out)

Amp Volatility Score:

TGTX

Jun 11-14, 2020

TG-1701

BTK Inhibitor

Phase 1 (EHA Data Presentation)

Amp Volatility Score:

KPTI

June 23, 2020

Selinexor (Xpovio)

Diffuse Large B -Cell Lymphoma DLBCL | SADAL

PDUFA

Amp Volatility Score:

ZGNX

Jun 25, 2020

FINTEPLA (ZX008)

Dravet syndrome

PDUFA Priority Review

Amp Volatility Score:

39%

ICPT

Jun 26, 2020

Ocaliva

Adult nonalcoholic steatohepatitis (NASH)

PDUFA Priority Review

Amp Volatility Score:

46%

HRTX

June 26, 2020

HTX-011

Post operative pain

PDUFA

Amp Volatility Score:

35%

AUPH

End of June 2020

Voclosporin

Lupus Nephritis

NDA Filing

Amp Volatility Score:

AIMT

Q2 2020

AR101 (Palforzia)

Peanut Allergy

Approved (Quarterly Sales)

Amp Volatility Score:

41%

ESPR

Q2 2020

Bempedoic Acid (Nexletol)

LDL-C is not adequately controlled with low- and moderate-dose statins

Approved (Quarterly Sales)

Amp Volatility Score:

32%

CARA

May-June 2020

Oral Korsuva

Atopic Dermatitis

Phase 2 (Interim Analysis/Top-line results)

Amp Volatility Score:

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

PROUDLY CREATED WITH WIX.COM

  • Twitter Social Icon
  • LinkedIn Social Icon